Raltegravir as Early Therapy in African-Americans Living With HIV Study (REAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00667433
Recruitment Status : Completed
First Posted : April 28, 2008
Last Update Posted : March 3, 2017
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
David A Wohl, MD, University of North Carolina, Chapel Hill